Literature DB >> 19679006

CCR9:CCL25 in melanoma metastatic to small intestine.

Kim A Margolin1.   

Abstract

Entities:  

Year:  2009        PMID： 19679006     DOI： 10.1007/s11912-009-0056-9

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


× No keyword cloud information.
  9 in total

1.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.

Authors:  A J Maniotis; R Folberg; A Hess; E A Seftor; L M Gardner; J Pe'er; J M Trent; P S Meltzer; M J Hendrix
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

Review 2.  Melanoma in the gastrointestinal tract.

Authors:  D Blecker; S Abraham; E E Furth; M L Kochman
Journal:  Am J Gastroenterol       Date:  1999-12       Impact factor: 10.864

Review 3.  Targeting STAT3 affects melanoma on multiple fronts.

Authors:  Marcin Kortylewski; Richard Jove; Hua Yu
Journal:  Cancer Metastasis Rev       Date:  2005-06       Impact factor: 9.264

4.  Functional CCR9 expression is associated with small intestinal metastasis.

Authors:  Anne Letsch; Ulrich Keilholz; Dirk Schadendorf; Geraldine Assfalg; Anne Marie Asemissen; Eckhard Thiel; Carmen Scheibenbogen
Journal:  J Invest Dermatol       Date:  2004-03       Impact factor: 8.551

5.  Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2.

Authors:  Jan Heidemann; Hitoshi Ogawa; Michael B Dwinell; Parvaneh Rafiee; Christian Maaser; Henning R Gockel; Mary F Otterson; David M Ota; Norbert Lugering; Wolfram Domschke; David G Binion
Journal:  J Biol Chem       Date:  2002-12-20       Impact factor: 5.157

6.  Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells.

Authors:  Takashi Murakami; Wusi Maki; Adela R Cardones; Hui Fang; Adrian Tun Kyi; Frank O Nestle; Sam T Hwang
Journal:  Cancer Res       Date:  2002-12-15       Impact factor: 12.701

Review 7.  The good and the bad of chemokines/chemokine receptors in melanoma.

Authors:  Ann Richmond; Jinming Yang; Yingjun Su
Journal:  Pigment Cell Melanoma Res       Date:  2009-02-14       Impact factor: 4.693

8.  CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors.

Authors:  C Monteagudo; J M Martin; E Jorda; A Llombart-Bosch
Journal:  J Clin Pathol       Date:  2006-03-07       Impact factor: 3.411

Review 9.  Chemokines as mediators of neovascularization.

Authors:  Ellen C Keeley; Borna Mehrad; Robert M Strieter
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-08-28       Impact factor: 8.311
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.